Adherence Inhibition of Cronobacter sakazakii to Intestinal Epithelial Cells by Lactoferrin

[1]  B. Lönnerdal,et al.  Longitudinal Changes in Lactoferrin Concentrations in Human Milk: A Global Systematic Review, , 2014, Critical reviews in food science and nutrition.

[2]  J. Bean,et al.  Cronobacter: an emerging opportunistic pathogen associated with neonatal meningitis, sepsis and necrotizing enterocolitis , 2013, Journal of Perinatology.

[3]  R. Read,et al.  Anti-adhesion methods as novel therapeutics for bacterial infections , 2012, Expert review of anti-infective therapy.

[4]  H. Ford,et al.  Human isolates of Cronobacter sakazakii bind efficiently to intestinal epithelial cells in vitro to induce monolayer permeability and apoptosis. , 2012, The Journal of surgical research.

[5]  B. Tall,et al.  Cronobacter species (formerly known as Enterobacter sakazakii) in powdered infant formula: a review of our current understanding of the biology of this bacterium , 2012, Journal of applied microbiology.

[6]  R. Hutkins,et al.  Adherence Inhibition of Cronobacter sakazakii to Intestinal Epithelial Cells by Prebiotic Oligosaccharides , 2011, Current Microbiology.

[7]  P. Whyte,et al.  Cronobacter (Enterobacter sakazakii): an opportunistic foodborne pathogen. , 2010, Foodborne pathogens and disease.

[8]  M. Garza,et al.  Bactericidal effect of bovine lactoferrin, LFcin, LFampin and LFchimera on antibiotic-resistant Staphylococcus aureus and Escherichia coli , 2010, BioMetals.

[9]  Li-Chun Lin,et al.  Cronobacter sakazakii in foods and factors affecting its survival, growth, and inactivation. , 2009, International journal of food microbiology.

[10]  J. Actor,et al.  Lactoferrin as a natural immune modulator. , 2009, Current pharmaceutical design.

[11]  A. Benson,et al.  Diet-Induced Metabolic Improvements in a Hamster Model of Hypercholesterolemia Are Strongly Linked to Alterations of the Gut Microbiota , 2009, Applied and Environmental Microbiology.

[12]  K. Yamauchi,et al.  Inhibitory effects of bovine lactoferrin and lactoferricin B on Enterobacter sakazakii. , 2008, Biocontrol science.

[13]  M. Loessner,et al.  Enterobacter sakazakii Invasion in Human Intestinal Caco-2 Cells Requires the Host Cell Cytoskeleton and Is Enhanced by Disruption of Tight Junction , 2007, Infection and Immunity.

[14]  T. Osaili,et al.  Isolation of Enterobacter sakazakii and other Enterobacter sp. from food and food production environments , 2007 .

[15]  L. G. Giugliano,et al.  Human Milk Glycoproteins Inhibit the Adherence of Salmonella typhimurium to HeLa Cells , 2006, Microbiology and immunology.

[16]  J. Gordon,et al.  Identification of lipopolysaccharide-binding proteins in porcine milk. , 2006, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.

[17]  G. Armstrong,et al.  Prebiotic Galactooligosaccharides Reduce Adherence of Enteropathogenic Escherichia coli to Tissue Culture Cells , 2006, Infection and Immunity.

[18]  C. Braden,et al.  Invasive Enterobacter sakazakii Disease in Infants , 2006, Emerging infectious diseases.

[19]  T. Ochoa,et al.  Effect of lactoferrin on enteroaggregative E. coli (EAEC). , 2006, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[20]  Nathan Sharon,et al.  Carbohydrates as future anti-adhesion drugs for infectious diseases. , 2006, Biochimica et biophysica acta.

[21]  Xiaoning Cai,et al.  Real time PCR using TaqMan and SYBR Green for detection of Enterobacter sakazakii in infant formula. , 2006, Journal of microbiological methods.

[22]  P. Valenti,et al.  Lactoferrin , 2005, Cellular and Molecular Life Sciences.

[23]  N. Orsi,et al.  The antimicrobial activity of lactoferrin: Current status and perspectives , 2004, Biometals.

[24]  R. W. Evans,et al.  Lactoferrin--a multifunctional protein with antimicrobial properties. , 2003, Molecular immunology.

[25]  C. Guzmán,et al.  Lactoferrin Impairs Type III Secretory System Function in Enteropathogenic Escherichia coli , 2003, Infection and Immunity.

[26]  M. Zimecki,et al.  Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS‐induced inflammatory responses in mice , 2002, Clinical and experimental immunology.

[27]  N. Sharon,et al.  Fighting Infectious Diseases with Inhibitors of Microbial Adhesion to Host Tissues , 2002, Critical reviews in food science and nutrition.

[28]  L. G. Giugliano,et al.  Lactoferrin and free secretory component of human milk inhibit the adhesion of enteropathogenic Escherichia coli to HeLa cells , 2001, BMC Microbiology.

[29]  K. Brandenburg,et al.  Biophysical Characterization of Lipopolysaccharide and Lipid A Inactivation by Lactoferrin , 2001, Biological chemistry.

[30]  K. K. Lai Enterobacter sakazakii Infections among Neonates, Infants, Children, and Adults: Case Reports and a Review of the Literature , 2001, Medicine.

[31]  N. Sharon,et al.  Safe as mother's milk: Carbohydrates as future anti-adhesion drugs for bacterial diseases , 2000, Glycoconjugate Journal.

[32]  Andrea Baroni,et al.  Lactoferrin Levels in Term and Preterm Milk , 2000, Journal of the American College of Nutrition.

[33]  H. Isoda,et al.  Inhibitory Effects of Bovine Lactoferrin on the Adherence of Enterotoxigenic Escherichia coli to Host Cells , 2000, Bioscience, biotechnology, and biochemistry.

[34]  B. Finlay,et al.  Enteropathogenic Escherichia coli: a pathogen that inserts its own receptor into host cells , 1999, Cellular and Molecular Life Sciences CMLS.

[35]  B. Finlay,et al.  Enteropathogenic E. coli, Salmonella, and Shigella: masters of host cell cytoskeletal exploitation. , 1999, Emerging infectious diseases.

[36]  E. Baker,et al.  Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[37]  B. Appelmelk,et al.  Lactoferrin is a lipid A-binding protein , 1994, Infection and immunity.

[38]  K. Yamauchi,et al.  Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment , 1993, Infection and immunity.

[39]  R. Arnold,et al.  Killing of Actinobacillus actinomycetemcomitans by human lactoferrin , 1988, Infection and immunity.

[40]  P. Visca,et al.  Enhanced antimicrobial activity of lactoferrin by binding to the bacterial surface. , 1988, Microbiologica.

[41]  R. Arnold,et al.  Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms , 1980, Infection and immunity.

[42]  H. Rogers,et al.  Iron-binding Proteins in Milk and Resistance to Escherichia coli Infection in Infants , 1972, Proceedings of the Royal Society of Medicine.

[43]  R. Hutkins,et al.  Adherence, anti-adherence, and oligosaccharides preventing pathogens from sticking to the host. , 2009, Advances in food and nutrition research.

[44]  R. Hancock,et al.  Antimicrobial properties of lactoferrin. , 2009, Biochimie.

[45]  A. Dugdale,et al.  A mixture containing galactooligosaccharide, produced by the enzymic activity of Bifidobacterium bifidum, reduces Salmonella enterica serovar Typhimurium infection in mice. , 2009, Journal of medical microbiology.

[46]  T. Ochoa,et al.  Effect of lactoferrin on enteric pathogens. , 2009, Biochimie.

[47]  D. Legrand,et al.  Lactoferrin structure and functions. , 2008, Advances in experimental medicine and biology.

[48]  T. Ochoa,et al.  Lactoferrin blocks the initial host cell attachment mechanism of Enteropathogenic E. coli (EPEC). , 2004, Advances in experimental medicine and biology.

[49]  T. Ochoa,et al.  Human lactoferrin impairs virulence of Shigella flexneri. , 2003, The Journal of infectious diseases.

[50]  I. Ofek,et al.  Bacterial adhesion to animal cells and tissues , 2003 .

[51]  O. Conneely,et al.  Lactoferrin and host defense. , 2002, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[52]  J. Brock The physiology of lactoferrin. , 2002, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[53]  D. Newburg,et al.  Protective role of human lactoferrin against invasion of Shigella flexneri M90T. , 2001 .